Questions about Peptide Therapy.

Peptides are short chains of amino acids that act as signaling molecules in the body. They occur naturally and direct a wide range of biological processes including tissue repair, hormone release, immune function, and cognitive performance. Therapeutic peptides are synthesised versions of these natural compounds, used at clinical doses to support or enhance specific physiological functions.

Common combinations include: Recovery (BPC-157 + TB-500 for injury healing and tissue repair), Growth hormone (CJC-1295 + Ipamorelin for body composition and recovery), Metabolic (AOD-9604 + MOTS-c for fat metabolism and insulin sensitivity), Cognitive (Cerebrolysin + Semax for focus and neuroprotection), and Longevity (Epithalon + GHK-Cu for cellular repair and anti-aging support). Your physician will design a stack appropriate to your goals and health profile.

The key difference is mechanism. Peptides work by stimulating your body's own natural processes: they signal hormone release, support tissue repair, or modulate immune responses. Steroids (anabolic steroids or synthetic hormones) bypass natural signaling and replace or amplify hormones directly. Peptides generally have a more targeted effect profile and do not suppress the body's own hormone production in the same way anabolic steroids do. Both require medical supervision.

Yes. Many peptides are used by women and are well-suited to female physiology. Commonly used peptides for women include GHK-Cu for skin and tissue health, Epithalon for longevity and circadian support, BPC-157 for healing, and Selank for stress resilience. Your physician will review your specific health profile before recommending any protocol.

Peptides can be administered in several ways depending on the compound. Injectable (subcutaneous): the most common method, using small insulin-style needles self-administered at home after instruction. Nasal spray: available for peptides such as Semax, Selank, PT-141, and Oxytocin. Oral capsules: available for some peptides including BPC-157 oral and MK-677. Topical cream: used for peptides such as GHK-Cu and Oligopeptide-34.

This depends on the peptide and your goal. Cognitive peptides such as Semax and Selank are often noticed within 1 to 3 weeks. Healing peptides like BPC-157 and TB-500 typically show effects over 4 to 8 weeks. Longevity and anti-aging peptides require longer protocols of 12 to 24 weeks before measurable changes. Your doctor will set realistic expectations during your consultation.

When prescribed by a licensed physician and sourced from a licensed compounding pharmacy, therapeutic peptides are generally well-tolerated. Side effects do occur and vary by peptide. Common ones include mild injection site reactions, temporary water retention with growth hormone peptides, or fatigue with certain compounds. Medical supervision allows these to be monitored and managed.

Yes, combining peptides (stacking) is common and often done intentionally to target complementary pathways. Your physician will design the combination based on your goals and will avoid potentially problematic overlaps. Not all peptides should be combined, which is one reason medical supervision is important.

Compounded peptides in Thailand are dispensed under physician prescription by licensed compounding pharmacies, which operate under Thai pharmaceutical regulations. They are not individually FDA-approved as pharmaceutical drugs, similar to the situation in many countries where compounded medications are legal when prescribed by a licensed practitioner.

Yes, with a valid prescription from a licensed Thai physician. Peptides prescribed by a registered doctor and dispensed by a licensed compounding pharmacy are legal in Thailand. Patients travelling internationally with prescribed peptides receive a physician letter and travel certificate describing their treatment.

Side effects are real and vary by compound. Growth hormone peptides (CJC-1295, Ipamorelin) may cause water retention, tingling, or temporary insulin sensitivity changes. BPC-157 is generally very well tolerated, with occasional nausea at higher doses. Selank and Semax may cause fatigue or mild irritation in some users. GLP-1 peptides may cause nausea and digestive discomfort, especially early in a protocol. Your physician will brief you on the specific side effects relevant to your protocol.

Current research does not support a causal link between therapeutic peptides used at clinical doses under medical supervision and cancer development. Some peptides such as BPC-157 and GHK-Cu have in fact been studied for potential anti-cancer properties, though this research is preliminary. Patients with a personal or family history of cancer should discuss this specifically with their physician before starting any protocol.

Both require medical supervision and carry their own risk profiles. TRT replaces testosterone directly, which can suppress the body's own production and requires monitoring of haematocrit, PSA, and cardiovascular markers. Peptides such as CJC-1295 or Kisspeptin stimulate natural hormone production rather than replacing it, generally preserving the feedback loop. Neither is inherently safer without context. Your physician can help you assess the appropriate approach for your situation.

Through a licensed physician. Peptides in Thailand are prescription-only. The process: you book a video or in-person consultation, your doctor reviews your history and goals, and if appropriate, writes a prescription that is filled by a licensed Thai compounding pharmacy. Peptides are then delivered to your address.

Yes. Video consultations are available for patients anywhere in Thailand. Once your protocol is confirmed and your prescription is issued, peptides are delivered in discreet, cold-chain packaging to your address. Bangkok, Phuket, Pattaya, Koh Samui, Hua Hin, and all other provinces are covered.

Baseline bloodwork is recommended and in some cases required before starting a protocol. The specific panels depend on your goals. For example, growth hormone peptides may require IGF-1 and fasting glucose; metabolic protocols require a full metabolic panel. Your doctor will advise on what is needed and where to get tests done near you.

Most protocols run between 8 and 24 weeks depending on the compounds and goals. Cognitive protocols are typically 8 to 12 weeks. Athletic recovery or anti-aging protocols often run 12 to 24 weeks. Your physician sets the length based on your objectives and the peptides involved.

Some peptides are dosed daily; others are dosed on a schedule of several times per week, or in cycles. Daily dosing is appropriate for many healing peptides such as BPC-157. Growth hormone peptides are often cycled to prevent receptor desensitisation. Your physician determines the right schedule.

Several peptides are studied for metabolic support and body composition. GLP-1 peptides (Semaglutide, Tirzepatide, Retatrutide) are clinically proven to reduce appetite and support significant weight loss, requiring careful titration and monitoring. AOD-9604 is a fragment of human growth hormone studied for fat metabolism. Tesamorelin is studied for visceral fat reduction. MOTS-c is a mitochondrial peptide investigated for insulin sensitivity and metabolic health. 5-Amino-1MQ is investigated for its effects on fat cell metabolism. The appropriate choice depends on your starting point and goals.

Yes. Compounded semaglutide is available from licensed Thai compounding pharmacies with a physician prescription. It is prepared under pharmaceutical-grade conditions with a Certificate of Analysis. This gives patients access to GLP-1 therapy at a significantly lower cost than branded versions available in Western countries.

For GLP-1 peptides, early effects on appetite are often noticeable within the first 2 to 4 weeks. Meaningful body composition changes typically appear after 8 to 12 weeks of consistent use at therapeutic doses. Metabolic peptides such as AOD-9604 and Tesamorelin work more gradually and are best assessed at the 12 to 16 week mark.

Most therapeutic peptides do not place a significant burden on the liver. Unlike oral anabolic steroids, injectable peptides are not metabolised through the same hepatic pathways. Some peptides such as BPC-157 have been studied for potential gastrointestinal and hepato-supportive effects. Liver function panels are included in baseline monitoring for protocols where oral compounds are used.

Most peptides do not raise blood pressure. Some growth hormone peptides may cause temporary fluid retention, which can mildly affect blood pressure in susceptible individuals. GLP-1 peptides such as semaglutide have actually shown cardiovascular benefits in clinical trials. Your physician will monitor blood pressure during your protocol if there is any relevant history.

It depends on the peptide. Kisspeptin can stimulate the body's own testosterone release through the HPG axis. Growth hormone peptides (CJC-1295, Ipamorelin) do not directly affect testosterone. Epithalon has been studied for effects on gonadotropin regulation in older adults. Unlike anabolic steroids, most peptides do not suppress natural testosterone production. Your physician can advise on peptides relevant to hormonal balance.

Several peptides are studied specifically for longevity and cellular health. Epithalon is a tetrapeptide studied for telomere support and regulation of the epiphysis. GHK-Cu is a copper peptide studied for collagen synthesis, wound healing, and anti-inflammatory effects. MOTS-c is a mitochondrial peptide investigated for cellular resilience and metabolic regulation. SS-31 is studied for mitochondrial protection. Humanin is investigated for neuroprotective and metabolic effects in aging.

Most therapeutic peptides at clinical doses do not have adverse effects on the heart. BPC-157 has been studied for potential cardioprotective properties. GLP-1 peptides such as semaglutide have demonstrated cardiovascular risk reduction in large clinical trials. Growth hormone peptides are monitored for potential effects on insulin sensitivity, which has downstream cardiovascular implications. Your doctor will assess any cardiac history before recommending a protocol.

Most therapeutic peptides are cleared by normal renal mechanisms without placing significant stress on the kidneys. Unlike nephrotoxic drugs, clinical-grade peptides at prescribed doses have not been associated with kidney damage in the available research. Patients with existing kidney disease or impaired renal function should disclose this during their consultation, as dose adjustments may be needed.